Zenith Capital Corp. (OTCPK: ZHCL.F)
Health Care · Biotechnology · CA
$0.05
+150.00% today · +24900.0% 1Y
Zenith Capital Corp. (OTCPK: ZHCL.F) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.99M.
Over the last twelve months the share price has gained 24900.0%, trading between 0.00 and 0.19.
Tweenvest scores Zenith Capital Corp. across four factors: quality 7/100, value 49/100. Its strongest factor is value.
ZHCL.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.99M
- Revenue (TTM)
- $500.00K
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 632.88
- 52-week high
- $0.19
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 159.73M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.60 | +0.62% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.00 | +0.15% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.98 | +0.59% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.19 | +0.03% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $842.16 | +0.97% |
| argenx SEENXTBR: ARGX | $65.85B | €875.60 | -2.93% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.84 | -0.85% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.